Correction: The topoisomerase I- and p53-binding protein topors is differentially expressed in normal and malignant human tissues and may function as a tumor suppressor (Oncogene, (2004), 23, 31, (5293-5300), 10.1038/sj.onc.1207700);The topoisomerase I- and p53-binding protein topors is differentially expressed in normal and malignant human tissues and may function as a tumor suppressor

Oncogene

Volumn 23, Issue 31, 2004, Pages 5293-5300

  Saleem, Ahamed ^a   Dutta, Jayeeta ^a   Malegaonkar, Diptee ^a   Rasheed, Farheena ^a   Rasheed, Zeshaan ^a   Rajendra, Rajeev ^a   Marshall, Henderson ^a   Luo, Minje ^a   Li, Honghua ^a   Rubin, Eric H ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

p53; Topoisomerase I; Topors; Tumor suppressor; Ubiquitin E3 ligase

Indexed keywords

BINDING PROTEIN; DNA TOPOISOMERASE; PROTEIN P53; PROTEIN TOPORS; UNCLASSIFIED DRUG; CARRIER PROTEIN; DNA BINDING PROTEIN; GREEN FLUORESCENT PROTEIN; MESSENGER RNA; NUCLEAR PROTEIN; PHOTOPROTEIN; THYMIDINE; TOPORS PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR PROTEIN; UBIQUITIN PROTEIN LIGASE;

ARTICLE; CANCER INHIBITION; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL GROWTH; CELL PROLIFERATION; COLON CANCER; CPG ISLAND; GENE LOCATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; MALIGNANT NEOPLASTIC DISEASE; METHYLATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; ADENOCARCINOMA; BIOSYNTHESIS; CELL CYCLE; CELL DIVISION; CELL STRAIN U937; COLON; COLON TUMOR; DNA METHYLATION; FLOW CYTOMETRY; HELA CELL; METABOLISM; PROTEIN TERTIARY STRUCTURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME; TISSUE DISTRIBUTION; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; CARRIER PROTEINS; CELL CYCLE; CELL DIVISION; COLON; COLONIC NEOPLASMS; CPG ISLANDS; DNA METHYLATION; DNA-BINDING PROTEINS; FLOW CYTOMETRY; G0 PHASE; G1 PHASE; GENES, TUMOR SUPPRESSOR; GREEN FLUORESCENT PROTEINS; HELA CELLS; HUMANS; LOSS OF HETEROZYGOSITY; LUMINESCENT PROTEINS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTEIN STRUCTURE, TERTIARY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THYMIDINE; TIME FACTORS; TISSUE DISTRIBUTION; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53; U937 CELLS; UBIQUITIN-PROTEIN LIGASES;

EID: 3142754273     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/s41388-019-0874-7     Document Type: Erratum

References (30)

1. Boutell C and Everett RD. (2003). J. Biol. Chem., 278, 36596-36602.
2. Boutell C, Sadis S and Everett RD. (2002). J. Virol., 76, 841-850.
3. Chang J, Dethlefsen LA, Barley LR, Zhou B and Cheng Y. (1992). Biochem. Pharm., 43, 2443-2452.
4. Chu D, Kakazu N, Gorrin-Rivas MJ, Lu HP, Kawata M, Abe T, Ueda K and Adachi Y. (2001). J. Biol. Chem., 276, 14004-14013.
5. Cui X, Feiner H, Lin Z and Li H. (2000). J. Mol. Diagn., 2, 29-36.
6. Devlin J, Elder PA, Gabra H, Steel CM and Knowles MA. (1996). Br. J. Cancer, 73, 420-423.
7. Dyck JA, Maul GG, Miller Jr WH, Chen JD, Kakizuka A and Evans RM. (1994). Cell, 76, 333-343.
8. Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW, Molloy PL and Paul CL. (1992). Proc. Nat. Acad. Sci. USA, 89, 1827-1831.
9. Giovanella BP, Stehlin JS, Wall ME, Wani MC, Nicholas AW, Liu LF, Silber R and Potmesil M. (1989). Science, 246, 1046-1048.
10. Haluska PH, Saleem A, Rasheed Z, Ahmed F, Su EW, Liu LF and Rubin EH. (1999). Nucleic Acids Res., 27, 2538-2544.
11. He D, Nan X, Chang KS, Wang Y and Chung LW. (2003). Chin. Med. J. (Engl.), 116, 1394-1398.
12. Herman JG, Merlo A, Mao L, Lapidus RG, Issa JP, Davidson NE, Sidransky D and Baylin SB. (1995). Cancer Res., 55, 4525-4530.
13. Joazeiro CA, Wing SS, Huang H, Leverson JD, Hunter T and Liu YC. (1999). Science, 286, 309-312.
14. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day 3rd RS, Johnson BE and Skolnick MH. (1994). Science, 264, 436-440.
15. Kim SK, Ro JY, Kemp BL, Lee JS, Kwon TJ, Fong KM, Sekido Y, Minna JD, Hong WK and Mao L. (1997). Cancer Res, 57, 400-403.
16. Li H and Hood L. (1995). Genomics, 26, 199-206.
17. Li LC and Dahiya R. (2002). Bioinformatics, 18, 1427-1431.
18. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB and Sidransky D. (1995), Nat. Med., 1, 686-692.
19. Narla G, Heath KE, Reeves HL, Li D, Giono LE, Kimmelman AC, Glucksman MJ, Narla J, Eng FJ, Chan AM, Ferrari AC, Martignetti JA and Friedman SL. (2001). Science, 294, 2563-2566.
20. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K and Carson DA. (1994). Nature, 368, 753-756.
21. Nuovo GJ, Plaia TW, Belinsky SA, Baylin SB and Herman JG. (1999). Proc. Natl. Acad. Sci. USA, 96, 12754-12759.
22. Perinchery G, Bukurov N, Nakajima K, Chang J, Li LC and Dahiya R. (1999). Int. J. Cancer, 83, 610-614.
23. Pollock PM, Welch J and Hayward NK. (2001). Cancer Res., 61, 1154-1161.
24. Puig S, Ruiz A, Lazaro C, Castel T, Lynch M, Palou J, Vilalta A, Weissenbach J, Mascaro JM and Estivill X. (1995). Am. J. Hum. Genet., 57, 395-402.
25. Rasheed ZA, Saleem A, Ravee Y, Pandolfi PP and Rubin EH. (2002). Exp. Cell Res., 277, 152-160.
26. Schraml P, Struckmann K, Bednar R, Fu W, Gasser T, Wilber K, Kononen J, Sauter G, Mihatsch MJ and Moch H. (2001). Am. J. Pathol., 158, 593-601.
27. Waber P, Dlugosz S, Cheng QC, Truelson J and Nisen PD. (1997). Oncogene, 15, 1699-1704.
28. Weger S, Hammer E and Engstler M. (2003). Exp. Cell Res., 290, 13-27.
29. Wiest JS, Franklin WA, Otstot JT, Forbey K, Varella-Garcia M, Rao K, Drabkin H, Gemmill R, Ahrent S, Sidransky D, Saccomanno G, Fountain JW and Anderson MW. (1997). Cancer Res., 57, 1-6.
30. Zhou R, Wen H and Ao SZ. (1999). Gene, 235, 93-101.